6533b7dbfe1ef96bd1270908
RESEARCH PRODUCT
MOESM2 of Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
Jan ScottDiego Hidalgo-mazzeiRebecca StrawbridgeAllan YoungMatthieu Resche-rigonBruno EtainOle AndreassenMichael BauerDjamila BennabiAndrew BlamireFawzi BoumezbeurPaolo BrambillaNadia CattaneAnnamaria CattaneoMarie ChupinKlara CoelloYann CointepasFrancesc ColomDavid CousinsCaroline DubertretEdouard DuchesnayAdele FerroAitana Garcia-estelaJose GoikoleaAntoine GrigisEmmanuel HaffenMargrethe Hă¸eghPetter JakobsenJanos KalmanLars KessingFarah Klohn-saghatolislamTrine LagerbergMikael LandăšnUte LewitzkaAshley LuttickeNicolas MazerMonica MazzelliCristina MoraThorsten MullerEstanislao Mur-milaKetil OedegaardLeif OltedalErik PăľlssonDimitri Papadopoulos OrfanosSergi PapiolVictor Perez-solaAndreas ReifPhilipp RitterRoberto RossiThomas SchulzeFanny SennerFiona SmithLetizia SquarcinaNils SteenPete ThelwallCristina VaroEduard Vieta VinbergMichele WessaLars WestlyeFrank Belliviersubject
3. Good healthdescription
Additional file 2: Appendix S2. Proposed list of instruments used for baseline clinical assessments and longitudinal monitoring of symptoms, medication adherence and lithium response.
year | journal | country | edition | language |
---|---|---|---|---|
2019-01-01 |